• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗叶酸药物甲氧苄啶和乙胺嘧啶盐中的超分子氢键模式。

Supramolecular hydrogen-bonding patterns in salts of the antifolate drugs trimethoprim and pyrimethamine.

作者信息

Swinton Darious Robert, Thomas Muthiah Packianathan, Perdih Franc

机构信息

School of Chemistry, Bharathidasan University, Tiruchirappalli 620 024, Tamilnadu, India.

Faculty of Chemistry and Chemical Technology, University of Ljubljana, Večna, pot 113, PO Box 537, SI-1000 Ljubljana, Slovenia.

出版信息

Acta Crystallogr C Struct Chem. 2018 Apr 1;74(Pt 4):487-503. doi: 10.1107/S2053229618004072. Epub 2018 Mar 23.

DOI:10.1107/S2053229618004072
PMID:29620034
Abstract

Nine salts of the antifolate drugs trimethoprim and pyrimethamine, namely, trimethoprimium [or 2,4-diamino-5-(3,4,5-trimethoxybenzyl)pyrimidin-1-ium] 2,5-dichlorothiophene-3-carboxylate monohydrate (TMPDCTPC, 1:1), CHNO·CHClOS, (I), trimethoprimium 3-bromothiophene-2-carboxylate monohydrate, (TMPBTPC, 1:1:1), CHNO·CHBrOS·HO, (II), trimethoprimium 3-chlorothiophene-2-carboxylate monohydrate (TMPCTPC, 1:1:1), CHNO·CHClOS·HO, (III), trimethoprimium 5-methylthiophene-2-carboxylate monohydrate (TMPMTPC, 1:1:1), CHNO·CHOS·HO, (IV), trimethoprimium anthracene-9-carboxylate sesquihydrate (TMPAC, 2:2:3), CHNO·CHO·1.5HO, (V), pyrimethaminium [or 2,4-diamino-5-(4-chlorophenyl)-6-ethylpyrimidin-1-ium] 2,5-dichlorothiophene-3-carboxylate (PMNDCTPC, 1:1), CHClN·CHClOS, (VI), pyrimethaminium 5-bromothiophene-2-carboxylate (PMNBTPC, 1:1), CHClN·CHBrOS, (VII), pyrimethaminium anthracene-9-carboxylate ethanol monosolvate monohydrate (PMNAC, 1:1:1:1), CHClN·CHO·CHOH·HO, (VIII), and bis(pyrimethaminium) naphthalene-1,5-disulfonate (PMNNSA, 2:1), 2CHClN·CHOS, (IX), have been prepared and characterized by single-crystal X-ray diffraction. In all the crystal structures, the pyrimidine N1 atom is protonated. In salts (I)-(III) and (VI)-(IX), the 2-aminopyrimidinium cation interacts with the corresponding anion via a pair of N-H...O hydrogen bonds, generating the robust R(8) supramolecular heterosynthon. In salt (IV), instead of forming the R(8) heterosynthon, the carboxylate group bridges two pyrimidinium cations via N-H...O hydrogen bonds. In salt (V), one of the carboxylate O atoms bridges the N1-H group and a 2-amino H atom of the pyrimidinium cation to form a smaller R(6) ring instead of the R(8) ring. In salt (IX), the sulfonate O atoms mimic the role of carboxylate O atoms in forming an R(8) ring motif. In salts (II)-(IX), the pyrimidinium cation forms base pairs via a pair of N-H...N hydrogen bonds, generating a ring motif [R(8) homosynthon]. Compounds (II) and (III) are isomorphous. The quadruple DDAA (D = hydrogen-bond donor and A = hydrogen-bond acceptor) array is observed in (I). In salts (II)-(IV) and (VI)-(IX), quadruple DADA arrays are present. In salts (VI) and (VII), both DADA and DDAA arrays co-exist. The crystal structures are further stabilized by π-π stacking interactions [in (I), (V) and (VII)-(IX)], C-H...π interactions [in (IV)-(V) and (VII)-(IX)], C-Br...π interactions [in (II)] and C-Cl...π interactions [in (I), (III) and (VI)]. Cl...O and Cl...Cl halogen-bond interactions are present in (I) and (VI), with distances and angles of 3.0020 (18) and 3.5159 (16) Å, and 165.56 (10) and 154.81 (11)°, respectively.

摘要

已制备了抗叶酸药物甲氧苄啶和乙胺嘧啶的九种盐,即甲氧苄啶鎓[或2,4 - 二氨基 - 5 - (3,4,5 - 三甲氧基苄基)嘧啶 - 1 - 鎓] 2,5 - 二氯噻吩 - 3 - 羧酸盐一水合物(TMPDCTPC,1:1),CHNO·CHClOS,(I);甲氧苄啶鎓3 - 溴噻吩 - 2 - 羧酸盐一水合物(TMPBTPC,1:1:1),CHNO·CHBrOS·HO,(II);甲氧苄啶鎓3 - 氯噻吩 - 2 - 羧酸盐一水合物(TMPCTPC,1:1:1),CHNO·CHClOS·HO,(III);甲氧苄啶鎓5 - 甲基噻吩 - 2 - 羧酸盐一水合物(TMPMTPC,1:1:1),CHNO·CHOS·HO,(IV);甲氧苄啶鎓蒽 - 9 - 羧酸盐倍半水合物(TMPAC,2:2:3),CHNO·CHO·1.5HO,(V);乙胺嘧啶鎓[或2,4 - 二氨基 - 5 - (4 - 氯苯基)-6 - 乙基嘧啶 - 1 - 鎓] 2,5 - 二氯噻吩 - 3 - 羧酸盐(PMNDCTPC,1:1),CHClN·CHClOS,(VI);乙胺嘧啶鎓5 - 溴噻吩 - 2 - 羧酸盐(PMNBTPC,1:1),CHClN·CHBrOS,(VII);乙胺嘧啶鎓蒽 - 9 - 羧酸盐乙醇单溶剂合物一水合物(PMNAC,1:1:1:1),CHClN·CHO·CHOH·HO,(VIII);以及双(乙胺嘧啶鎓)萘 - 1,5 - 二磺酸盐(PMNNSA,2:1),2CHClN·CHOS,(IX),并通过单晶X射线衍射对其进行了表征。在所有晶体结构中,嘧啶N1原子被质子化。在盐(I) - (III)和(VI) - (IX)中,2 - 氨基嘧啶鎓阳离子通过一对N - H...O氢键与相应阴离子相互作用,生成稳定的R(8)超分子杂合成子。在盐(IV)中,羧酸盐基团不是形成R(8)杂合成子,而是通过N - H...O氢键桥连两个嘧啶鎓阳离子。在盐(V)中,羧酸盐的一个O原子桥连嘧啶鎓阳离子的N1 - H基团和一个2 - 氨基H原子,形成一个较小的R(6)环而非R(8)环。在盐(IX)中,磺酸盐O原子在形成R(8)环基序中模拟了羧酸盐O原子的作用。在盐(II) - (IX)中,嘧啶鎓阳离子通过一对N - H...N氢键形成碱基对,生成一个环基序[R(8)同合成子]。化合物(II)和(III)是同构的。在(I)中观察到四重DDAA(D = 氢键供体,A = 氢键受体)阵列。在盐(II) - (IV)和(VI) - (IX)中,存在四重DADA阵列。在盐(VI)和(VII)中,DADA和DDAA阵列共存。晶体结构通过π - π堆积相互作用[在(I)、(V)和(VII) - (IX)中]、C - H...π相互作用[在(IV) - (V)和(VII) - (IX)中]、C - Br...π相互作用[在(II)中]以及C - Cl...π相互作用[在(I)、(III)和(VI)中]进一步稳定。在(I)和(VI)中存在Cl...O和Cl...Cl卤键相互作用,距离和角度分别为3.0020 (18)和3.5159 (16) Å,以及165.56 (10)和154.81 (11)°。

相似文献

1
Supramolecular hydrogen-bonding patterns in salts of the antifolate drugs trimethoprim and pyrimethamine.抗叶酸药物甲氧苄啶和乙胺嘧啶盐中的超分子氢键模式。
Acta Crystallogr C Struct Chem. 2018 Apr 1;74(Pt 4):487-503. doi: 10.1107/S2053229618004072. Epub 2018 Mar 23.
2
Supramolecular interactions in salts/cocrystals involving pyrimidine derivatives of sulfonate/carboxylic acid.涉及磺酸盐/羧酸嘧啶衍生物的盐/共晶体中的超分子相互作用。
Acta Crystallogr C Struct Chem. 2023 Feb 1;79(Pt 2):61-67. doi: 10.1107/S2053229623000177. Epub 2023 Jan 23.
3
Supramolecular interactions in carboxylate and sulfonate salts of 2,6-diamino-4-chloropyrimidinium.2,6-二氨基-4-氯嘧啶鎓羧酸盐和磺酸盐中的超分子相互作用
Acta Crystallogr C Struct Chem. 2017 Jul 1;73(Pt 7):536-540. doi: 10.1107/S2053229617008798. Epub 2017 Jun 16.
4
Supramolecular architectures in the salt trimethoprimium ferrocene-1-carboxylate and the cocrystal 4-amino-5-chloro-2,6-dimethylpyrimidine-ferrocene-1-carboxylic acid (1/1).盐三甲基季铵铁茂 - 1 - 羧酸盐和共晶体4 - 氨基 - 5 - 氯 - 2,6 - 二甲基嘧啶 - 铁茂 - 1 - 羧酸(1/1)中的超分子结构
Acta Crystallogr C Struct Chem. 2017 Sep 1;73(Pt 9):743-748. doi: 10.1107/S2053229617011913. Epub 2017 Aug 18.
5
Hydrogen-bonding patterns in trimethoprim picolinate and 2-amino-4,6-dimethylpyrimidinium picolinate hemihydrate.甲氧苄啶吡啶甲酸盐和2-氨基-4,6-二甲基嘧啶吡啶甲酸盐半水合物中的氢键模式。
Acta Crystallogr C. 2006 Feb;62(Pt 2):o107-10. doi: 10.1107/S0108270105037856. Epub 2006 Jan 31.
6
Eight salt forms of sulfadiazine.磺胺嘧啶的八种盐形式。
Acta Crystallogr C Struct Chem. 2014 Sep;70(Pt 9):900-7. doi: 10.1107/S2053229614018725. Epub 2014 Aug 27.
7
Hydrogen-bonded supramolecular motifs in 2-amino-4,6-dimethoxypyrimidinium picrate and pyrimethaminium picrate dimethyl sulfoxide solvate.苦味酸2-氨基-4,6-二甲氧基嘧啶鎓盐和苦味酸乙胺嘧啶鎓盐二甲亚砜溶剂化物中的氢键超分子基序
Acta Crystallogr C. 2009 Feb;65(Pt 2):o42-5. doi: 10.1107/S0108270108044223. Epub 2009 Jan 10.
8
Aminopyrimidine-carboxyl(ate) interactions in trimethoprim maleate, an antifolate drug.抗叶酸药物马来酸甲氧苄啶中氨基嘧啶-羧基(酯)的相互作用
Acta Crystallogr C. 2001 Apr;57(Pt 4):459-61. doi: 10.1107/s0108270101000269.
9
Supramolecular architectures in cytosinium 6-chloronicotinate monohydrate and 5-bromo-6-methylisocytosinium hydrogen sulfate.6-氯烟酸胞嘧啶鎓一水合物和硫酸氢5-溴-6-甲基异胞嘧啶鎓中的超分子结构
Acta Crystallogr C Struct Chem. 2018 Mar 1;74(Pt 3):325-331. doi: 10.1107/S2053229618002462. Epub 2018 Feb 21.
10
Hydrogen-bonded supramolecular motifs in pyrimethaminium 4-methylbenzoate, pyrimethaminium 3-hydroxypicolinate and pyrimethaminium 2,4-dichlorobenzoate.4-甲基苯甲酸乙胺嘧啶盐、3-羟基吡啶甲酸乙胺嘧啶盐和2,4-二氯苯甲酸乙胺嘧啶盐中的氢键超分子基序
Acta Crystallogr C. 2010 Mar;66(Pt 3):o104-8. doi: 10.1107/S0108270110002337. Epub 2010 Feb 3.

引用本文的文献

1
Evaluating the Effect of Epigallocatechin Gallate (EGCG) in Reducing Folate Levels in Reproductive Aged Women by MTHFR and DHFR Genotype in Combination With Letrozole or Clomiphene.评估表没食子儿茶素没食子酸酯(EGCG)联合来曲唑或克罗米芬通过MTHFR和DHFR基因型降低育龄妇女叶酸水平的效果。
Clin Transl Sci. 2025 Mar;18(3):e70189. doi: 10.1111/cts.70189.
2
Differences in Coformer Interactions of the 2,4-Diaminopyrimidines Pyrimethamine and Trimethoprim.2,4-二氨基嘧啶类药物乙胺嘧啶和甲氧苄啶共形成物相互作用的差异。
Cryst Growth Des. 2022 May 4;22(5):3163-3173. doi: 10.1021/acs.cgd.2c00035. Epub 2022 Apr 8.
3
Dihydrofolate Reductase Inhibitors: The Pharmacophore as a Guide for Co-Crystal Screening.
二氢叶酸还原酶抑制剂:基于药效团的共晶筛选。
Molecules. 2021 Nov 6;26(21):6721. doi: 10.3390/molecules26216721.